The soft corals of Lord Howe Island, approximately 700 kilometres northeast of Sydney, are demonstrating greater resilience to coral bleaching than the hard corals of the island, marine biologists have found. Led by the University of New South Wales (NSW), the team surveyed the island’s coral reef—the world’s most southern—during, immediately after, and seven months…
Soft Corals Show Greater Resilience to Bleaching During Marine Heatwaves
Italy Creates New Museum for Trafficked Ancient Artifacts
ROME—Italy has been so successful in recovering ancient artworks and artifacts that were illegally exported from the country it has created a museum for them. The Museum of Rescued Art was inaugurated Wednesday in a cavernous structure that is part of Rome’s ancient Baths of Diocletian. The Octagonal Hall exhibition space was designed to showcase…
European Star Survey Reveals Celestial Treasure Trove
BERLIN—The European Space Agency released a trove of data Monday on almost 2 billion stars in the Milky Way, collected by its Gaia space observatory in an effort to create the most accurate and complete map of our galaxy. Astronomers hope to use the data to understand better how stars are born and die, and…
Nanoparticle Cures Sepsis in Mice, Potentials for Future Treatment
The use of engineered nicotinamide adenine dinucleotide [NAD(H)], a molecule common to many animals, resulted in 100 percent sepsis survival in mice, creating a potential future treatment, a University of Wisconsin-Madison study has found. Researchers from the study say the NAD(H) nanoparticles also have the potential to treat many other diseases because NAD(H) is involved…
Plastic Eating Worms Show Promise for Plant-Scale Recycling
Researchers at the University of Queensland have found that a common species of worm with a taste for polystyrene may significantly contribute to plastic recycling. The team, led by Dr Chris Rinke from UQ’s School of Chemistry and Molecular Biosciences, found that the Zophobas morio—known as ‘superworm’—enjoys munching on polystyrene and can metabolise it due to…
New Tech May Open Up the World of Gaming to Disabled Individuals
Researchers from the University of Sydney are developing a 3D printed sensor bracelet that could allow individuals living with hand impairment to easily use computers and play video games that require handheld controllers. People with cerebral palsy and motor neurone disease struggle with hand movement, preventing them from gaming or using computers. However, this new…
Research Shows Plastic Pollution on Australia’s Beaches Is Declining
New research by Australia’s Commonwealth Scientific and Industrial Research Organisation (CSIRO) has revealed that plastic pollution on Australia’s beaches has decreased by almost a third since 2013. Lead researcher and recent PhD graduate from CSIRO and the University of Tasmania, Kathryn Willis, said in a release on Thursday that waste control is generally driven at a local…
Consumer Confidence Warning Over ‘Frankenscience’ Gene-Edited Animal Plans in England
The British government says its plan to legalise gene-editing in animals and plants for food is following the science and will help ensure food security. But critics say profits are driving what they call “frankenscience” and warn consumer confidence could be hit. The new Genetic Technology Bill, the government says, will allow the creation of…
Some Cancer Patients Can Skip Treatments, 2 Studies Show
After surgery, some cancer patients can safely skip radiation or chemotherapy, according to two studies exploring shorter, gentler cancer care. Researchers are looking for ways to precisely predict which cancer patients can avoid unneeded treatment to cut down on harmful side effects and unnecessary costs. One new study used a blood test to determine which…
Gilead Drug Modestly Delays Breast Cancer Progression in Late-Stage Trial
Gilead Sciences Inc.’s Trodelvy extended by 1.5 months, or 34 percent, the length of time women with advanced stages of a common type of breast cancer lived without their disease worsening, according to trial data presented on Saturday. The Phase III study compared Trodelvy to chemotherapy in 543 patients with hormone-sensitive tumors that test negative…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`